mRNA platforms moving beyond vaccines into new disease areas
Messenger RNA platforms have evolved well past their original role as vaccine tools, extending into oncology, rare conditions, cardiovascular therapies, and other fields as scientific validation, production efficiencies, regulatory experience, and persistent clinical gaps converge. The very attributes that supported swift action during the pandemic are now being applied to transform the way medicines are conceived and delivered.From Proof of Concept to Broad Clinical ConfidenceThe worldwide rollout of mRNA vaccines offered extensive real-world confirmation that synthetic mRNA can be effective, scalable, and generally well tolerated, with hundreds of millions of administered doses showing that short-lived protein production can trigger strong…
